Battle of Thermopylae: 300 Spartans (natural killer cells plus obinutuzumab) versus the immortal warriors (chronic lymphocytic leukemia cells) of Xerxes’ army
Keywords:
ADCC
Chronic lymphocytic leukemia
Follicular lymphoma
GA101
Ibrutinib
NK cells
Obinutuzumab
Subcutaneous rituximab
Publisher:
Future Science Ltd
Note:
This work is licensed under the Creative Commons Attribution 4.0 License. To view a copy of this license, visit http://creativecomm
ons.org/licenses/by/4.0/
Citation:
Garcia-Muñoz, R. (R.); Nájera, M.J. (María Josefa); Feliu, J. (Jesús); et al. "Battle of Thermopylae: 300 Spartans (natural killer cells plus obinutuzumab) versus the immortal warriors (chronic lymphocytic leukemia cells) of Xerxes’ army". Future Science OA. 5 (10), 2019, FSO425
Statistics and impact
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.